Checkpoint Therapeutics to Present at the 2019 H.C. Wainwright Global Life Sciences Conference Apr 03, 2019
Mustang Bio Announces $20 Million Venture Debt Financing Agreement with Horizon Technology Finance Apr 01, 2019
Fortress Biotech Reports Fourth Quarter and Full-Year 2018 Financial Results and Recent Corporate Highlights Mar 18, 2019
Checkpoint Therapeutics Reports Full-Year 2018 Financial Results and Recent Corporate Highlights Mar 15, 2019
Avenue Therapeutics Reports Full Year 2018 Financial Results and Recent Corporate Highlights Mar 12, 2019
Mustang Bio and Nationwide Children’s Hospital Enter into Exclusive Worldwide License Agreement for Oncolytic Virus (C134) to Treat Glioblastoma Multiforme Feb 20, 2019
